6 min read
Engineering Healthcare Innovation: Top 10 Medical Device Design Firms
Behind many successful medical devices are design and engineering firms that provide the technical expertise, regulatory knowledge, and development...
Traditional CROs fragment device development with costly hand-offs and learning curves. Veranex unites the essential disciplines for medical device & diagnostic development under one roof from sketch to evidence-generation to market launch.
All connected. All aligned. All accelerating your path to market—delivering breakthrough devices and diagnostics that improve patient lives sooner.
Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.
Purpose-built solutions. Proven results. User & Patient-centered innovation.
Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity. Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.
We are the Innovation CRO.
Legacy of excellence. Proven execution. Patient impact accelerated.
6 min read
Behind many successful medical devices are design and engineering firms that provide the technical expertise, regulatory knowledge, and development...
3 min read
Contributors: Naghmeh Nouri, Nick Benedetto The Art of the Specific Question for FDA Pre-Submission Guidance and Human Factors FDA pre-submission...
3 min read
Institutions and enterprises around the world are pushing the boundaries of medical innovation by applying advanced robotic technologies to address...
2 min read
The human factors team at Veranex has reviewed the NMPA Guidance Draft 01 and Draft 02 and submitted feedback to the agency. We’re committed to...
5 min read
By Matt Gottschalk